|
⚲
|
| Keyboard |
| Clarus IV GP LP | |
|---|---|
| Firm | Clarus Ventures LLC |
| Address | c/o Clarus Ventures, LLC 101 Main Street, Suite 1210 Cambridge, MA 02142 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Clarus Ventures LLC | |||||
| Clarus IV-A LP | 021-286937 | Director | 789.7 M of 880.0 M |
217.3 M | |
| Clarus IV-B LP | 021-286939 | Director | 789.7 M of 880.0 M |
139.5 M | |
| Clarus IV-C LP | 021-286940 | Director | 789.7 M of 880.0 M |
257.5 M | |
| Clarus IV-D LP | 021-286941 | Director | 789.7 M of 880.0 M |
51.4 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tourmaline Bio Inc TALS
Series B Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 696,767 | ||
|
Tourmaline Bio Inc TALS
Series B Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 562,891 | ||
|
Tourmaline Bio Inc TALS
Series A-1 Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 1,476,924 | ||
|
Tourmaline Bio Inc TALS
Series A-1 Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 1,944,371 | ||
|
Tourmaline Bio Inc TALS
Series A-1 Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 3,692,307 | ||
|
Tourmaline Bio Inc TALS
Series A Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 26,000,000 | ||
|
Tourmaline Bio Inc TALS
Series B Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 135,334 | ||
|
Tourmaline Bio Inc TALS
Series B Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 676,774 | ||
|
Tourmaline Bio Inc TALS
Series B Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 366,918 | ||
|
Tourmaline Bio Inc TALS
Series A-1 Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 3,586,364 | ||
|
Tourmaline Bio Inc TALS
Series A-1 Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 717,160 | ||
|
Tourmaline Bio Inc TALS
Series A-1 Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 2,982,874 | ||
|
Tourmaline Bio Inc TALS
Series B Convertible Preferred Stock · derivative
|
2021-05-11 | Conversion | 278,707 | ||
|
Tourmaline Bio Inc TALS
Common Stock
|
2021-05-11 | Conversion | 130,236 | ||
|
Tourmaline Bio Inc TALS
Common Stock
|
2021-05-11 | Conversion | 52,094 | ||
|
Tourmaline Bio Inc TALS
Common Stock
|
2021-05-11 | Conversion | 105,213 | ||
|
Tourmaline Bio Inc TALS
Common Stock
|
2021-05-11 | Conversion | 68,582 | ||
|
Tourmaline Bio Inc TALS
Common Stock
|
2021-05-11 | Conversion | 126,499 | ||
|
Tourmaline Bio Inc TALS
Common Stock
|
2021-05-11 | Conversion | 25,296 | ||
|
Tourmaline Bio Inc TALS
Common Stock
|
2021-05-11 | Buy | 15,918 | $17.00 | 270,606 |
| showing 20 of 45 most recent transactions | |||||